Cerenome, Inc.(CNSY)

Medical - Pharmaceuticals · Houston, TX

$1.60+0.04 (+2.56%)

Delayed quote: Oct 6, 2026, 12:35 PM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T16:41:43.045Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:41:43.045Z.

Quote observation: 2026-10-06T16:35:10.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 1.6
Unrounded diluted TTM EPS · period ending 2026-06-30: -4.43

FMP input reference: 7e5dd7cae71be814523bfc9444594aa14e5919ebae0d9bfc7936539f469f7652

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

CNSY PE Ratio Metrics

PE RATIO

N/A

CNSY Competitors' PE Ratio

CNSY

Cerenome, Inc.

Current

Market Cap

$11.01M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BIVI

BioVie Inc.

vs CNSY

Market Cap

$11.12M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ADIL

Adial Pharmaceuticals, Inc.

vs CNSY

Market Cap

$11.19M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CABR

Caring Brands, Inc.

vs CNSY

Market Cap

$10.73M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KPRX

Kiora Pharmaceuticals, Inc.

vs CNSY

Market Cap

$11.17M

PE Ratio

N/A

TTM Avg

2.43

3Y Avg

2.43

5Y Avg

2.43

PLRZ

Polyrizon Ltd.

vs CNSY

Market Cap

$10.68M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BFRI

Biofrontera Inc.

vs CNSY

Market Cap

$11.42M

PE Ratio

N/A

TTM Avg

9.63

3Y Avg

9.63

5Y Avg

9.63

GDTC

CytoMed Therapeutics Limited

vs CNSY

Market Cap

$10.52M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PLUR

Pluri Inc.

vs CNSY

Market Cap

$11.54M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PHIO

Phio Pharmaceuticals Corp.

vs CNSY

Market Cap

$11.61M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Cerenome, Inc. (CNSY)	$11.01M	N/A	N/A	N/A	N/A
BioVie Inc. (BIVI)vs ›	$11.12M	N/A	N/A	N/A	N/A
Adial Pharmaceuticals, Inc. (ADIL)vs ›	$11.19M	N/A	N/A	N/A	N/A
Caring Brands, Inc. (CABR)vs ›	$10.73M	N/A	N/A	N/A	N/A
Kiora Pharmaceuticals, Inc. (KPRX)vs ›	$11.17M	N/A	2.43	2.43	2.43
Polyrizon Ltd. (PLRZ)vs ›	$10.68M	N/A	N/A	N/A	N/A
Biofrontera Inc. (BFRI)vs ›	$11.42M	N/A	9.63	9.63	9.63
CytoMed Therapeutics Limited (GDTC)vs ›	$10.52M	N/A	N/A	N/A	N/A
Pluri Inc. (PLUR)vs ›	$11.54M	N/A	N/A	N/A	N/A
Phio Pharmaceuticals Corp. (PHIO)vs ›	$11.61M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$1.60

Forward EPS (Est.)

$-4.75

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

CNSY PE Ratio Metrics

CNSY Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics